Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sci Rep ; 11(1): 11835, 2021 06 04.
Artigo em Inglês | MEDLINE | ID: mdl-34088935

RESUMO

There is still a lack of competing risk analysis of patients with papillary renal cell carcinoma (pRCC) following surgery. We performed the cumulative incidence function (CIF) to estimate the absolute risks of cancer-specific mortality (CSM) and other-cause mortality (OCM) of pRCC over time, and constructed a nomogram predicting the probability of 2-, 3- and 5-year CSM based on competing risk regression. A total of 5993 pRCC patients who underwent nephrectomy between 2010 and 2016 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The 2-, 3-, 5-year CSM rates were 3.2%, 4.4% and 6.5%, respectively, and that of OCM were 3.2%, 5.0% and 9.3%, respectively. The estimates of 5-year cumulative mortality were most pronounced among patients aged > 75 years in OCM (17.0%). On multivariable analyses, age, tumor grade, T stage, N stage, and with or without bone, liver and lung metastases were identified as independent predictors of CSM following surgery and were integrated to generate the nomogram. The nomogram achieved a satisfactory discrimination with the AUCt of 0.730 at 5-year, and the calibration curves presented impressive agreements. Taken together, age-related OCM is a significant portion of all-cause mortality in elderly patients and our nomogram can be used for decision-making and patient counselling.


Assuntos
Carcinoma de Células Renais/mortalidade , Neoplasias Renais/mortalidade , Nomogramas , Análise de Sobrevida , Idoso , Área Sob a Curva , Calibragem , Carcinoma de Células Renais/epidemiologia , Tomada de Decisões , Feminino , Humanos , Incidência , Neoplasias Renais/epidemiologia , Masculino , Oncologia/métodos , Pessoa de Meia-Idade , Análise Multivariada , Metástase Neoplásica , Estadiamento de Neoplasias , Nefrectomia/métodos , Probabilidade , Curva ROC , Estudos Retrospectivos , Risco , Fatores de Risco , Programa de SEER , Software , Estados Unidos , Urologia/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA